Table 1.
Characteristics | Disease-free survival rate (%) | 5-year survival rate (%) | ||||
---|---|---|---|---|---|---|
MRP-1/CD9 + | MRP-1/CD9 − | P value | MRP-1/CD9 + | MRP-1/CD9 − | P value | |
Age at surgery (years) | ||||||
≤50 | 68.8 | 45.9 | 0.0409 | 96.2 | 83.7 | 0.1855 |
>50 | 63.9 | 28.6 | 0.0013 | 92.8 | 76.2 | 0.0815 |
ER status | ||||||
+ | 66.2 | 45.0 | 0.0244 | 100.0 | 90.0 | 0.4000 |
− | 64.4 | 34.3 | 0.0081 | 88.7 | 70.3 | 0.0587 |
Tumor status | ||||||
T1 | 95.2 | 44.4 | 0.0005 | 100.0 | 100.0 | >0.9999 |
T2 | 52.0 | 52.9 | 0.4539 | 90.3 | 83.7 | 0.4179 |
T3 | 80.0 | 25.0 | 0.0570 | 100.0 | 75.0 | >0.9999 |
T4 | 100.0 | 0.0 | >0.9999 | 100.0 | 33.3 | >0.9999 |
Nodal status | ||||||
N0 | 93.0 | 45.0 | 0.0007 | 100.0 | 85.6 | 0.2000 |
N1 | 52.5 | 33.9 | 0.0438 | 90.1 | 85.1 | 0.6659 |
N2 | 40.0 | 0.0 | 0.2536 | 66.7 | 0.0 | 0.0445 |
Pathological stage | ||||||
I | 93.8 | 37.5 | 0.0168 | 100.0 | 100.0 | >0.9999 |
II | 69.5 | 46.3 | 0.0249 | 93.2 | 81.5 | 0.1302 |
III | 55.6 | 14.3 | 0.0887 | 85.7 | 68.6 | 0.3759 |
Total number of patients | 65.7 | 37.7 | 0.0005 | 94.0 | 80.8 | 0.0380 |